TrialBritish journal of clinical pharmacology2026

Infusion rate adjustment in enzyme replacement therapy with pabinafusp alfa for mucopolysaccharidosis II.

Kimitoshi Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.